BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2020
View Archived Issues
Stromal cell subtypes identified in TNBC
Read More
From variants to treatments in neurology
Read More
New selective NKCC1 inhibitor for neurological conditions with impaired chloride ion homeostasis
Read More
LION/repRNA-CoV2S vaccine candidate shows efficacy in vivo
Read More
Phase III data presented for incobotulinumtoxin A in post-stroke upper-limb spasticity
Read More
Beijing Scitech-Mq Pharmaceuticals patents multitarget inhibitors
Read More
New phosphodiesterase PDE3A and PDE3B inhibitors disclosed by Bayer, The Broad Institute
Read More
Medshine Discovery discovers PD-L1 expression inhibitors
Read More
Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical identify agents targeting 5-HT2A/DRD3
Read More
Aeovian Pharmaceuticals identifies new mTORC1 inhibitors
Read More
Vivozon halts phase III study of opiranserin due to COVID-19 outbreak in the U.S.
Read More
Homozygous mutations in BTG4 are responsible for the phenotype of zygotic cleavage failure
Read More
FDA approves Enspryng for neuromyelitis optica spectrum disorder
Read More
Missense variants in the TRIP13 gene cause oocyte meiotic arrest resulting in female infertility
Read More
Discovery of autoantibody biomarkers for SLE diagnosis using a 2-phase proteome microarray strategy
Read More
Dosing initiates in phase IIa study of ASC-22 in patients with chronic hepatitis B
Read More
Starpharma and Chase Sun to develop novel DEP nanoparticle formulations
Read More
Specific miRNA-1 oxidation encodes cardiac hypertrophy
Read More
Kiadis announces K-NK-cell technology program for the development of COVID-19 therapy
Read More
Novavax initiates phase IIb efficacy trial of NVX-CoV2373 in South Africa
Read More